PMID: 6401551Feb 5, 1983Paper

Dietary sodium restriction for mild hypertension in general practice

British Medical Journal
G C WattC J Foy

Abstract

Eighteen patients with stable mild hypertension (mean blood pressure 144/93 mm Hg) restricted their sodium intake for eight weeks while taking part in a double blind randomised crossover trial of slow sodium and placebo tablets. Mean 24 hour urinary sodium excretion was 143 mmol(mEq) during the period on slow sodium and 87 mmol during the period on placebo. Five patients were unable to reduce their sodium intake below 120 mmol, but the others had a mean 24 hour urinary sodium excretion of 59 mmol during the period on placebo. There was no significant difference in blood pressure between the slow sodium and placebo treatment periods, although the study had a power of 99% to detect a difference of 5 mm Hg in mean arterial pressure between the two periods. Moderate dietary sodium restriction does not lower blood pressure in patients with this degree of hypertension.

References

Feb 4, 1978·Lancet·T MorganS Carney
Jul 1, 1979·British Journal of Clinical Pharmacology·M Hills, P Armitage
Jan 9, 1982·British Medical Journal·D G Beevers
Dec 1, 1981·Clinical Science·C T Dollery
Feb 4, 1982·The New England Journal of Medicine·M F Oliver
Apr 1, 1948·The American Journal of Medicine·W KEMPNER

❮ Previous
Next ❯

Citations

Aug 15, 1988·Klinische Wochenschrift·T IwaokaI Kawakami
Mar 30, 1985·British Medical Journal·N A Boon, J K Aronson
Jul 5, 1986·British Medical Journal·D E Grobbee, A Hofman
Jun 22, 1991·BMJ : British Medical Journal·J T HartP Walton
Sep 1, 1984·Journal of Epidemiology and Community Health·J S Robertson
Jun 1, 1987·Journal of Epidemiology and Community Health·R J JarrettT Murrells
Jan 1, 1984·Postgraduate Medical Journal·J T Hart
Mar 1, 1991·Postgraduate Medical Journal·G W Ching, D G Beevers
Jan 1, 1990·Clinical and Experimental Hypertension. Part A, Theory and Practice·K D WuT S Chu
Feb 1, 1989·Kidney International·D A McCarron
Apr 22, 2017·Research Synthesis Methods·François Curtin
Dec 1, 1984·The American Journal of Medicine·A P NiarchosJ H Laragh
Mar 1, 1987·Preventive Medicine·S E EversI R McWhinney
Oct 30, 1987·The American Journal of Cardiology·E D Frohlich
Oct 30, 1987·The American Journal of Cardiology·M H Walczyk, D A McCarron
Apr 10, 2017·The Cochrane Database of Systematic Reviews·Niels Albert GraudalGesche Jurgens
Nov 12, 2003·Hypertension·Feng J He, Graham A MacGregor
Jul 1, 1984·Clinical and Experimental Pharmacology & Physiology·A M RichardsJ E Wells
Aug 10, 2007·Current Hypertension Reports·Daniel T Lackland, Brent M Egan
Jun 1, 1990·Journal of Internal Medicine·A JulaJ Mäki
Sep 1, 1986·The Proceedings of the Nutrition Society·P M DodsonS P Waldron
May 2, 2013·The Cochrane Database of Systematic Reviews·Feng J HeGraham A Macgregor
Feb 20, 2004·The Cochrane Database of Systematic Reviews·L HooperS Ebrahim
Sep 26, 2020·Journal of the American Heart Association·Jinming FuYashuang Zhao
Jan 1, 1985·Acta Medica Scandinavica. Supplementum·J K HuttunenP Puska
Sep 1, 1986·The Proceedings of the Nutrition Society·D G Beevers
Jul 7, 2020·EFSA Journal·UNKNOWN EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)Androniki Naska
Dec 15, 2020·The Cochrane Database of Systematic Reviews·Niels Albert GraudalGesche Jurgens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.